Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension

Free Subscription 18.05.2026 1 Adv Ther 1 Am J Physiol Lung Cell Mol Physiol 1 Ann Am Thorac Soc 1 Ann Pediatr Cardiol 1 Arterioscler Thromb Vasc Biol 1 Arthritis Rheumatol 1 Bioorg Chem 1 BMC Cardiovasc Disord 1 Cardiol Young 1 Catheter Cardiovasc Interv 4 Chest 2 Circulation 1 Clin Rheumatol 2 Curr Probl Cardiol 1 EBioMedicine 1 ERJ Open Res 1 Eur J Case Rep Intern Med 1 Eur J Pharmacol 1 Eur Respir Rev 1 Front Cardiovasc Med 1 High Alt Med Biol 1 Indian J Pediatr 1 Int J Cardiol Heart Vasc 1 Ital J Pediatr 1 J Med Chem 1 J Thorac Cardiovasc Surg 1 J Vet Intern Med 1 JACC Case Rep 1 Nutr Rev 1 Pan Afr Med J 1 Pulm Circ 2 Respir Med Res 1 Therapie 1 Toxicol Appl Pharmacol 7 Zhonghua Yi Xue Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Adv Ther

1. FORD HJ, Chin KM, Fan F, Friberg M, et al
   Long-Term Treatment with Single-Tablet Combination of Macitentan and Tadalafil in Pulmonary Arterial Hypertension: Results from A DUE and Its Open-Label Period.
   Adv Ther. 2026;43:2106-2124.
   PubMed         Abstract available
   
   

   
   Am J Physiol Lung Cell Mol Physiol

2. HIRSCH K, Horn AG, Donato AJ, Schulze KM, et al
   The right time, the right cell: the potential for precision senotherapy in pulmonary arterial hypertension.
   Am J Physiol Lung Cell Mol Physiol. 2026;330:L661-L669.
   PubMed         Abstract available
   
   

   
   Ann Am Thorac Soc

3. TARRAS ES, Garcia MF, Leary PJ
   Sex Differences in Chronic Thromboembolic Pulmonary Hypertension: Beyond Biology.
   Ann Am Thorac Soc. 2026 May 12:aaoag130. doi: 10.1093.
   PubMed        
   
   

   
   Ann Pediatr Cardiol

4. SANTOSH W, Arpita M, Moreshwar BA, Parveen RS, et al
   Pediatric pulmonary hypertension registry: Single-center experience from India.
   Ann Pediatr Cardiol. 2026;19:14-22.
   PubMed         Abstract available
   
   

   
   Arterioscler Thromb Vasc Biol

5. FENG H, Lai J, Yang X, Cui X, et al
   Integrated Single-Cell Atlas Reveals Cross-Subtype Heterogeneity in Human Pulmonary Hypertension.
   Arterioscler Thromb Vasc Biol. 2026 May 14. doi: 10.1161/ATVBAHA.126.324594.
   PubMed         Abstract available
   
   

   
   Arthritis Rheumatol

6. LUI JK, Patel R, Luong HL, Au M, et al
   Cytokine Profiling of Systemic Sclerosis-related Pulmonary Hypertension.
   Arthritis Rheumatol. 2026 May 11. doi: 10.1002/art.70222.
   PubMed         Abstract available
   
   

   
   Bioorg Chem

7. MU Y, Sun J, Zhang X, Zhu H, et al
   The novel PDE5 inhibitor CPD1 attenuates pulmonary arterial hypertension through dual modulation of cGMP and TRPM8-mediated pathways.
   Bioorg Chem. 2026;177:109908.
   PubMed         Abstract available
   
   

   
   BMC Cardiovasc Disord

8. YAVUZ YE, Alsancak Y, Tatar S, Korucu C, et al
   TAPSE/PAi, a practical echocardiographic functional-structural index, better reflects functional severity than TAPSE/sPAP in pulmonary hypertension.
   BMC Cardiovasc Disord. 2026 May 8. doi: 10.1186/s12872-026-05920.
   PubMed         Abstract available
   
   

   
   Cardiol Young

9. GREMONT S, Ronkainen E, Kallio M
   Gap between guidelines and practice: echocardiography reporting in neonatal pulmonary hypertension.
   Cardiol Young. 2026 May 11:1-6. doi: 10.1017/S104795112611292.
   PubMed         Abstract available
   
   

   
   Catheter Cardiovasc Interv

10. HU J, Yao F
    Pulmonary Artery Denervation for Refractory Sjogren's Syndrome-Associated Pulmonary Arterial Hypertension: A Case Report of Combined Hemodynamic and Renal Recovery.
    Catheter Cardiovasc Interv. 2026;107:1847-1850.
    PubMed         Abstract available
    
    

    
    Chest

11. AZARINE A, Kasani K, Kim YW, Sakhi H, et al
    The importance of Post-Processing Methods for Assessing Right Ventricular Volumes and Function in Patients with Pulmonary Hypertension: results from the PRINCEPT study.
    Chest. 2026 May 13:S0012-3692(26)00557-X. doi: 10.1016/j.chest.2026.
    PubMed        
    
    
12. HON SM, Goel K, George MP, Farber HW, et al
    Evolving Representation in Pulmonary Hypertension: Recent Insights and Challenges.
    Chest. 2026;169:1313-1316.
    PubMed        
    
    
13. BEGHETTI M, Axelsen LN, Borissoff JI, Farhan M, et al
    A Prospective, Multicenter, Open-Label, Single-Arm Phase 2 Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Exploratory Efficacy of Selexipag in Children With Pulmonary Arterial Hypertension.
    Chest. 2026;169:1330-1344.
    PubMed         Abstract available
    
    
14. QIAN J, Yang X, Wang Q, Zhao J, et al
    Association of Rare Variants in Pulmonary Arterial Hypertension-Related Genes With a Distinct Vasculopathy Phenotype and Worse Outcomes in Patients With Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
    Chest. 2026;169:1317-1329.
    PubMed         Abstract available
    
    

    
    Circulation

15. SARMA S, Chin KM
    Stepping Into a New Era: Sotatercept for the Treatment of Combined Precapillary and Postcapillary Pulmonary Hypertension From Heart Failure With Preserved Ejection Fraction.
    Circulation. 2026;153:1460-1462.
    PubMed        
    
    
16. ZHANG Y, Bonnet S, Provencher S, Piao J, et al
    A Critical Contribution of Cardiac Myofibroblasts in Right Ventricular Failure and the Role of UCP2 SNPs in the Predisposition to RV Decompensation in Pulmonary Arterial Hypertension.
    Circulation. 2026 Mar 9. doi: 10.1161/CIRCULATIONAHA.125.078674.
    PubMed         Abstract available
    
    

    
    Clin Rheumatol

17. CHANG SH, Yeh FC, Chen PK, Yeo KJ, et al
    The presence of anti-Ro52/SSA antibodies may predict concomitant pulmonary hypertension and poorer survival in patients with connective tissue disease-associated interstitial lung disease.
    Clin Rheumatol. 2026 May 11. doi: 10.1007/s10067-026-08151.
    PubMed         Abstract available
    
    

    
    Curr Probl Cardiol

18. GARCIA-CESAR M, Cueto-Robledo G, Roldan-Valadez E, Torres-Rojas MB, et al
    Management of pulmonary arterial hypertension with intermediate-high-risk pulmonary embolism during pregnancy: Diagnostic challenges, catheter-directed thrombolysis, and intravenous treprostinil - A narrative review with an institutional case snapshot
    Curr Probl Cardiol. 2026;51:103337.
    PubMed         Abstract available
    
    
19. ZHU R, Liu X, Shen Y, Zhu S, et al
    Endothelial cell metabolic reprogramming and pulmonary hypertension: Research progress and therapeutic potential.
    Curr Probl Cardiol. 2026;51:103360.
    PubMed         Abstract available
    
    

    
    EBioMedicine

20. VALLELIAN F, Schaer DJ, Lechartier B, Buehler PW, et al
    Sickle cell disease-associated pulmonary hypertension: an integrated framework linking pathologies, mechanisms, and clinical phenotypes.
    EBioMedicine. 2026;128:106288.
    PubMed         Abstract available
    
    

    
    ERJ Open Res

21. HERBERT S, Dimopoulos K, Jenkin I, Dawes TJW, et al
    Assessment of noninvasive parameters prior to diagnosis of pulmonary hypertension in patients with fibrotic interstitial lung disease.
    ERJ Open Res. 2026;12:01231-2025.
    PubMed         Abstract available
    
    

    
    Eur J Case Rep Intern Med

22. JOMA M, Karam AM, Sawaf B, Sayeh W, et al
    Whipple's Disease Complicated by Severe Pulmonary Hypertension and Right Ventricular Failure.
    Eur J Case Rep Intern Med. 2026;13:006600.
    PubMed         Abstract available
    
    

    
    Eur J Pharmacol

23. LU YY, Lin FJ, Chen YC, Chin CG, et al
    Bradykinin modulates endothelin-1-enhanced and monocrotaline-induced pulmonary arterial hypertension-associated arrhythmogenesis in rabbit right ventricular outflow tract via a nitric oxide-dependent pathway.
    Eur J Pharmacol. 2026;1024:178896.
    PubMed         Abstract available
    
    

    
    Eur Respir Rev

24. CONDLIFFE R, Aman J, Boucly A, Cerrone E, et al
    Diagnostic and management dilemmas in pulmonary hypertension.
    Eur Respir Rev. 2026;35:250337.
    PubMed         Abstract available
    
    

    
    Front Cardiovasc Med

25. FENG J, Xia X, Li J, Wang X, et al
    Bilateral coronary artery fistulas with progressive aortic regurgitation presenting as persistent atrial fibrillation, acute heart failure and pulmonary hypertension: a case report.
    Front Cardiovasc Med. 2026;13:1776492.
    PubMed         Abstract available
    
    

    
    High Alt Med Biol

26. SHRESTHA S, Kharel S, Acharya S, Basyal G, et al
    A Retrospective Analysis of Altitude Illness at the Himalayan Rescue Association Aid Post Manang (2018-2023).
    High Alt Med Biol. 2026;27:87-92.
    PubMed         Abstract available
    
    

    
    Indian J Pediatr

27. RABHA KD, Kundavaram R, Soni P, Kumar A, et al
    Prevalence and Risk Factors for Pulmonary Hypertension in Children with Sickle Cell Disease: A Prospective Observational Study from Central India.
    Indian J Pediatr. 2026 May 12. doi: 10.1007/s12098-026-06175.
    PubMed        
    
    

    
    Int J Cardiol Heart Vasc

28. MASSALHA E, Dakka A, Marai I, Michowitz Y, et al
    Impact of pulmonary hypertension on atrial fibrillation recurrence after pulmonary vein isolation: A prospective multicenter registry study.
    Int J Cardiol Heart Vasc. 2026;64:101935.
    PubMed         Abstract available
    
    

    
    Ital J Pediatr

29. EL AMROUSY D, Koura H, Abdou N, Awny M, et al
    Hemodynamic effects of high frequency oscillatory ventilation versus conventional mechanical ventilation in term neonates with persistent pulmonary hypertension: a single-center randomized trial.
    Ital J Pediatr. 2026;52:84.
    PubMed         Abstract available
    
    

    
    J Med Chem

30. HU Y, Wang Y, Tan W, Zhao C, et al
    Identification of Nitric Oxide-Donating Lenumlostat Derivatives with Dual Activities of Extracellular Matrix Dysregulation Inhibition and Pulmonary Vasodilation for the Treatment of Pulmonary Arterial Hypertension.
    J Med Chem. 2026;69:11448-11470.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

31. SHENTU J, Shi G, Chen H
    Reply: Pulmonary venous remodeling takes center stage in model of group 2 pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2026 May 9:S0022-5223(26)00851.
    PubMed        
    
    

    
    J Vet Intern Med

32. CHANG WT, Lin CK, Chang CH, Lo PY, et al
    Long-term follow-up of bronchomalacia after bronchoscopy: survival and prognostic factors in dogs.
    J Vet Intern Med. 2026;40:aalag082.
    PubMed         Abstract available
    
    

    
    JACC Case Rep

33. BALMORI GT, Alania Torres EM, Rodriguez Pichardo YM, Utrilla AC, et al
    Reversible Dasatinib-Associated Pulmonary Hypertension Managed With Dual Therapy and Hemodynamic-Guided Withdrawal.
    JACC Case Rep. 2026 May 8:108164. doi: 10.1016/j.jaccas.2026.108164.
    PubMed         Abstract available
    
    

    
    Nutr Rev

34. JIN Y, Ding L, Fan M, Kong N, et al
    Association of Vitamin Deficiency With Pulmonary Arterial Hypertension: A Review.
    Nutr Rev. 2026;84:1227-1238.
    PubMed         Abstract available
    
    

    
    Pan Afr Med J

35. YON LCN, Kengni HNT, Sharau G, Nkya D, et al
    Surgical management of complex congenital heart diseases in the context of South-South cooperation: case series.
    Pan Afr Med J. 2026;53:21.
    PubMed         Abstract available
    
    

    
    Pulm Circ

36. HE A, Lu Y, Liu X, Liang J, et al
    Associations of Red Blood Cell Distribution Width-Derived Indicators and Their Longitudinal Dynamic Trajectories With Mortality Risk in Critically Ill Patients With Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70314.
    PubMed         Abstract available
    
    

    
    Respir Med Res

37. GRYNBLAT J, Eyries M, Ambar-Akkaoui M, Levy M, et al
    The preponderance of genetic variations in paediatric pulmonary hypertension.
    Respir Med Res. 2026;89:101277.
    PubMed         Abstract available
    
    
38. MIHAI A
    Cardiac MRI and the "lung phenotype" in pulmonary hypertension: Overlap with group 3 or distinct entity?
    Respir Med Res. 2026;89:101272.
    PubMed        
    
    

    
    Therapie

39. MAZEPA C, Mur S, Gascoin G, Storme L, et al
    Descriptive study of the effects of treprostinil and/or epoprostenol in newborn infants with inhaled NO refractory persistent pulmonary hypertension of the newborn (PPHN).
    Therapie. 2026 Mar 18:S0040-5957(26)00047-8. doi: 10.1016/j.therap.2026.
    PubMed         Abstract available
    
    

    
    Toxicol Appl Pharmacol

40. WU B, Tian T, Liu Y, Qin S, et al
    The critical role of HIBCH in pulmonary arterial hypertension.
    Toxicol Appl Pharmacol. 2026;511:117779.
    PubMed         Abstract available
    
    

    
    Zhonghua Yi Xue Za Zhi

41. XIONG CM, Zhai ZG, Liu ZH
    [Thirty years of targeted drug therapy for pulmonary hypertension: the therapeutic paradigm transition from "vasodilation" to "reverse remodeling"].
    Zhonghua Yi Xue Za Zhi. 2026;106:1739-1743.
    PubMed         Abstract available
    
    
42. LUO Q, Liu ZH
    [Current status and evolution of targeted therapy for pulmonary arterial hypertension in China].
    Zhonghua Yi Xue Za Zhi. 2026;106:1744-1749.
    PubMed         Abstract available
    
    
43. CUI XD, Chen JY, Wang J
    [Innovations in targeted therapies for pulmonary hypertension: advancing from vasodilation to vascular remodeling].
    Zhonghua Yi Xue Za Zhi. 2026;106:1750-1755.
    PubMed         Abstract available
    
    
44. LUO CJ, Wang L
    [Advances in targeted therapy for pulmonary arterial hypertension].
    Zhonghua Yi Xue Za Zhi. 2026;106:1756-1761.
    PubMed         Abstract available
    
    
45. YAO H, Zhang Y
    [Advances in targeted pharmacotherapies for pulmonary hypertension associated with left heart disease].
    Zhonghua Yi Xue Za Zhi. 2026;106:1762-1766.
    PubMed         Abstract available
    
    
46. LIU L, Yang YH
    [Progress in targeted drug therapy for pulmonary hypertension associated with hypoxia].
    Zhonghua Yi Xue Za Zhi. 2026;106:1767-1774.
    PubMed         Abstract available
    
    
47. ZHANG M, Hu XH, Wan J
    [Progress in targeted therapy for chronic thromboembolic pulmonary hypertension].
    Zhonghua Yi Xue Za Zhi. 2026;106:1775-1780.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum